Cancer News: Cervical
Advanced radiotherapy better tolerated in cervical and endometrial cancer
Intensity-modulated radiation therapy (IMRT) causes less side effects in cervical and endometrial cancer than conventional radiotherapy (RT).
Cervical cancer survival affected by weight
Weight influenced the survival time of overweight and underweight women with cervical cancer, a new study shows.
Cervical cancer: less side effects with specialized radiation therapy
Cervical cancer patients had less bowel side effects when treated with image-guided intensity-modulated radiation therapy, a new study reveals.
Brachytherapy combination shown to benefit cervical cancer patients
Combining two forms of brachytherapy (a type of radiation therapy) against cervical cancer was shown to deliver higher dose without an increase in side-effects.
New treatment for cervical cancer recommended in Europe
Bevacizumab (Avastin) has been recommended as a treatment for cervical cancer patients, expanding its current marketing authorization.
Some cervical cancer patients benefit from experimental drug in trial
Cervical cancer that has spread elsewhere, or has recurred after treatment, shrunk more when doctors added an experimental drug to standard chemotherapy.
Combined IV bevacizumab approved for recurrent metastatic cervical cancer
The US FDA has approved bevacizumab for intravenous infusion for treatment of persistent, recurrent or metastatic cervical cancer, combined with other drugs.
Lowering gynecologic cancer risk
There are several things women can do to lower their risk of developing certain types of cancer and improve their chances for survival if they do develop one of them, according to the Society of Gynecologic Oncology (SGO).
Food toxins related to cervical and liver cancer
Food such as corn tortilla, rice, chili pepper, processed sauces, chicken breast and eggs, are related with cervical and liver cancer in humans, according to scientists.
Cervical cancer diagnostic device gets certified in Europe
ZedScan, a device for diagnosing cervical cancer, has received EC certification allowing its use in the European Union.
HPV and ovarian cancer: why are HPV vaccination rates low?
A new study attempts to explain why some young women at high risk for cervical cancer do not get the HPV vaccine.
Low HPV vaccination among autoimmune disease patients
Few children and young adults with autoimmune diseases receive the HPV vaccination, despite studies showing the vaccine to be safe and effective.
Women with abnormal cancer screening may receive delayed care due to social barriers
Social barriers (including housing and income) cause delays in cancer screening follow-up for some women, according to a recent study.
Screening for HPV may be better than Pap Test, study suggests
Screening for the human papillomavirus (HPV) is more effective than Pap tests for protecting women against invasive cervical cancer, a new study suggests.
Primary HPV screening provides 60–70% greater protection against invasive cervical cancer than cytology-based screening
Primary screening for HPV (Human Papilloma Virus) provides 60–70% greater protection against invasive cervical cancer than the cytology-based (‘smear-test’) screening currently used in most countries where cervical screening is available, according to new results published in The Lancet.
One dose of HPV vaccine may be enough
A single dose of human papillomavirus vaccine (HPV) achieved stable antibody levels at 48 months, suggesting that one dose of vaccine might afford adequate protection, according to a study from Central America.
Low-risk women screening rates by female doctors are higher
Many criteria affect HPV screening rates among low-risk women. The most important may be whether their doctor is male or female.
Internet-based intervention improves cancer-related sexual dysfunction in women
An Internet-based intervention may significantly improve both sexual function and satisfaction in women with sexual dysfunction years after treatment for breast or gynecologic cancer, according to a randomized trial reported in the November issue of the Journal of the National Comprehensive Cancer Network. Leslie R. Schover, PhD, of The University of Texas MD Anderson Cancer Center, and colleagues also found that the intervention may reduce emotional distress and improve the overall quality of life in these women after treatment.
Barriers to HPF vaccination among teens
Barriers to human papillomavirus (HPV) vaccination among adolescents in the U.S. range from financial concerns and parental attitudes to social influences and concerns about the vaccination's effect on sexual behavior, according to a review of the available medical literature published by JAMA Pediatrics, a JAMA Network publication.
Older women still getting Pap smears despite guidelines
Women who've had a hysterectomy, and most women over 65, don't need regular swabs for signs of cervical cancer - but lots of them are getting the test anyway, say U.S. researchers.
Cervical cancer risk could be identified by HPV self-tests
HPV self-testing is as effective as tests done by doctors, according to a Lund University study. Simple HPV home tests could therefore complement existing screening programs, and identify more women at risk for cervical cancer.
Genomic study of cervical cancer completed by international team
Researchers from 3 countries have completed a genomic analysis of cervical cancer, including at least one genetic mutation for which targeted treatments have been approved for other forms of cancer.
Early HPV vaccination leads to better protection
Getting the HPV vaccine after the age of 18 leads to similar outcomes with no vaccination at all, according to investigators.
Cervical cancer diagnosis and staging through simple test
Cervical cancer diagnosis and stage indication via a blood-based test has been demonstrated, which can help in prompt treatment.
Protein controlling cervical cancer drivers analyzed
Researchers analyzed the structure of a cervical cancer related protein (called E6AP) in high detail.
Cervical cancer screening important in women over 50 too
Women over 50 not screened for cervical cancer have 6 times the risk to be diagnosed in later life.
New cervical cancer treatments may target a recently identified gene
Latest research on cervical cancer identified a gene as a potential target to stop the tumor's growth. This development may improve future treatment options.
HPV virus responsible for cervical cancer killed by HIV drug in trials
In a localized trial, a large portion of women with HPV-positive early stage cervical cancer returned to normal after being treated with the HIV drug lopinavir.
Survival with advanced cervical cancer prolonged by bevacizumab
Combining chemotherapy with bevacizumab (also known as Avastin) extended survival in patients with advanced cervical cancer who participated in a phase 3 trial.
Cervical cancer protection through HPV vaccination confirmed
The protection against cervical abnormalities, including cancer, offered by the HPV vaccine was further confirmed by a new research conducted in Australia.